Skip to content
Resources > Reports

Key Debates Transforming Healthcare and Life Sciences in 2026

By Sara Mallatt, Director of Healthcare Research
IndustryLife Sciences & Healthcare, Financial Services

So far 2026 has been a year of transition for healthcare and life sciences. Over the first half of this year, we’ve analyzed the individual stories moving the needle across the life sciences ecosystem as part of our Sector Spotlight series. The eight spotlights that follow in this recap capture a cross-section of this momentum: featuring the high-stakes battles for new drug markets (like oral GLP-1s and targeted radioligand therapies), a resurgent biotech IPO market, and the operational turnarounds keeping the back-end engine of medicine moving forward.

Follow the sector’s key debates during 2H26 and beyond, with our latest Sector Spotlights directly in AlphaSense. These eight debates include:

  • CYTK vs. BMY in oHCM
  • GSK’s Ozureprubart for Allergic Conditions
  • Aktis Oncology vs. Novartis
  • SpyGlass Pharma IPO
  • Oral GLP1 Market
  • Doximity: Reacceleration Prospects
  • Avantor: Turnaround Progress
  • uniQure: AMT130 for Huntingtonʼs Disease
About the Author
  • Sara Mallatt

    Sara Mallatt, Director of Healthcare Research

    Sara has more than 18 years of experience generating sell-side research content across a variety of industries. Prior to joining AlphaSense, Sara held leadership positions at OTR Global, a leading channel research firm, most recently as Director of Healthcare Research. Sara holds a bachelor’s degree in journalism and a master’s in industrial engineering. She works from her home in Missoula, Montana.

Explore more

All articles

Top AI Use Cases for Venture Capital Firms

In this report, discover how venture capital teams are leveraging AI for decision-grade intelligence that distills signal from noise in a crowded environment.
ReportFinancial Services
A blue graphic titled "Top AI Use Cases for Venture Capital Firms" featuring an upward trending arrow, a stack of money, and a globe.

Top AI Use Cases for Law Firms

As generative AI compresses traditional billable hours and reshapes client expectations, elite law firms are fundamentally changing how they operate. Discover the top use cases that are transforming how elite law firms are winning mandates and driving business development in the AI era.
ReportAI
Top AI Use Cases for Law Firms title next to a light blue gavel and sound block on a grid.

The 2026 State of AI for Business and Finance

Among AI-engaged leaders and decision-makers, adoption is close to universal this year, and the daily payoff is real. Accuracy has become the No. 1 feature buyers want in an AI tool — ahead of privacy, output quality, and speed.
ReportAI
The 2026 State of AI for Business and Finance, From Adoption to Accountability.

Transform intelligence
into advantage

Develop bold strategies, seize opportunities,
and lead with clarity and confidence.